Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1,662 |
|
|||||
| News | - | ||||||
| Day High | 6.67 | Low High |
|||||
| Day Low | 6.20 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Precipio Inc | PRPO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.505 | -7.53% | 6.20 | 16:24:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.67 | 6.20 | 6.67 | 6.20 | 6.705 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 70 | 1,662 | $ 6.36 | $ 10,569 | - | 4.7515 - 14.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 31 | $ 6.47 | USD |
Precipio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.8M | 1.42M | - | 15.2M | -5.85M | -4.12 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Precipio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRPO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.77 | 6.95 | 6.20 | 6.69 | 1,251 | -0.57 | -8.42% |
| 1 Month | 6.26 | 7.00 | 5.98 | 6.51 | 4,571 | -0.06 | -0.96% |
| 3 Months | 6.27 | 7.25 | 5.82 | 6.52 | 5,274 | -0.07 | -1.12% |
| 6 Months | 6.68 | 8.99 | 5.0039 | 6.84 | 6,379 | -0.48 | -7.19% |
| 1 Year | 13.062 | 14.80 | 4.7515 | 7.75 | 68,515 | -6.86 | -52.53% |
| 3 Years | 37.00 | 183.60 | 4.7515 | 88.64 | 1,383,671 | -30.80 | -83.24% |
| 5 Years | 10.89 | 216.00 | 4.7515 | 78.13 | 1,325,571 | -4.69 | -43.07% |
Precipio Description
| Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provide new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. |
